查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美直接面對消費者的基因測試市場預測至 2030 年 - 區域分析 - 按測試類型、技術和配銷通路
市場調查報告書
商品編碼
1463715

北美直接面對消費者的基因測試市場預測至 2030 年 - 區域分析 - 按測試類型、技術和配銷通路

North America Direct-to-Consumer Genetic Testing Market Forecast to 2030 - Regional Analysis - by Test Type, Technology, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 75 Pages | 訂單完成後即時交付

價格

2022年北美直接面對消費者的基因檢測市值為7.164億美元，預計到2030年將達到30.4112億美元；預計2022年至2030年CAGR為19.8%。

遺傳疾病發生率不斷上升推動了北美直接面對消費者的基因檢測市場

遺傳疾病的全球負擔正在增加。根據《衛報》2022 年發表的一篇文章，全球約 5% 的人口受到鐮狀細胞疾病的影響，全球每年約有 30 萬名嬰兒出生時患有鐮狀細胞貧血症。世界衛生組織估計，每 1,000 人中就有 10 人受到影響。這意味著全世界有 7,000 至 8,000 萬人患有其中一種疾病。 2020 年，線上人類孟德爾遺傳 (OMIM) 資源列出了 6,594 種已知分子遺傳缺陷的疾病，包括 4,225 個基因。根據 Orphanet 和 OMIM 資料庫，這一數字持續增加，每年約有 50-60 種新的遺傳疾病。美國國立衛生研究院未確診疾病計畫和網路以及國際罕見疾病研究聯盟等措施進一步加快了新型遺傳疾病的發現速度。

根據疾病預防控制中心的數據，每 500 名非裔美國人中就有 1 人被診斷出患有鐮狀細胞疾病，每 12 名非裔美國人中就有 1 人攜帶常染色體隱性突變。據阿茲海默症協會稱，到 2023 年，近 670 萬 65 歲的美國人將患有阿茲海默症相關的失智症。此外，到 2060 年，這一數字預計將增至 1,380 萬，而目前還沒有減緩或治癒這種疾病的突破。

新生兒遺傳性疾病的發生率也在增加。根據世界衛生組織2022年報告，神經管缺陷、唐氏症和心臟缺陷是幾種常見的嚴重先天性殘疾。據美國疾病預防控制中心 (CDC) 稱，在美國，唐氏症每年影響近 6,000 名新生兒，即每 700 名嬰兒中就有一名患有唐氏症；在印度，每年有近 23,000 至 29,000 名兒童（即 831 名兒童中就有一名）患有唐氏症。根據2021年《家庭醫學和初級保健雜誌》發表的題為“神經管缺陷：不同類型以及神經形成過程及其臨床意義的簡要概述”的報告，超過30萬例神經管缺陷（NTD）病例每年在世界範圍內都有記錄。這些因素鼓勵對遺傳性疾病進行基因檢測。

因此，全球遺傳性疾病發生率的增加促進了直接面對消費者的基因檢測市場的成長。

北美直接面對消費者的基因檢測市場概述

北美直接面對消費者的基因檢測市場分為美國、加拿大和墨西哥。由於遺傳疾病的日益普及、研發支出的高額、美國食品藥物管理局 (FDA) 的產品批准以及技術的進步，北美佔據了重要的市場佔有率。大型醫療保健企業的存在以及直接面對消費者的基因檢測的日益普及將繼續為 2022 年至 2030 年期間該地區的市場成長提供機會。此外，政府為解決對遺傳疾病日益成長的擔憂而提供的支持不斷增加，有利於北美直接面對消費者的基因檢測市場的進步。

北美直接面對消費者的基因檢測市場收入及 2030 年預測（百萬美元）

北美直接面對消費者的基因檢測市場區隔

北美直接面對消費者的基因測試市場分為測試類型、技術、配銷通路和國家。

根據測試類型，北美直接面對消費者的基因測試市場分為血統測試、預測測試、營養基因組學測試、帶因者測試等。 2022 年，血統測驗細分市場佔據最大佔有率。

從技術上來看，北美直接面對消費者的基因檢測市場分為全基因組定序、單核苷酸多態性晶片、標靶分析等。 2022年，單核苷酸多態性晶片領域佔據最大佔有率。

根據配銷通路，北美直接面對消費者的基因檢測市場分為線上和線下。 2022 年，線上細分市場佔據了更大的佔有率。

根據國家/地區，北美直接面對消費者的基因檢測市場分為美國、加拿大和墨西哥。 2022 年，美國在北美直接面對消費者的基因檢測市場佔據主導地位。

Ancestry Genomics Inc、Color Health Inc、Helix Inc、Myriad Genetics, Inc.、Living DNA Ltd、23andMe Inc、Genetic Technologies Ltd、Gene by Gene Ltd 和 Full Genomes Corp Inc 是在北美直接營運的一些領先公司-對消費者的基因檢測市場。

目錄

表中的內容

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美直接面對消費者的基因檢測市場格局

  • 概述
  • PEST分析

第 5 章：北美直接面對消費者的基因檢測市場 - 主要產業動態

  • 市場促進因素
    • 遺傳性疾病的發生率不斷上升
    • 提高對基因檢測潛在益處的認知
  • 市場限制
    • 與直接面對消費者的基因檢測相關的高成本和隱私問題
  • 市場機會
    • 單核苷酸多態性 (SNP) 晶片的採用日益廣泛
  • 未來的趨勢
    • 人們對藥物基因學的興趣日益濃厚，遠距醫療的採用也不斷增加
  • 影響分析

第 6 章：直接面對消費者的基因檢測市場 - 北美市場分析

  • 概述
  • 北美直接面對消費者的基因檢測市場收入，2022 - 2030

第 7 章：北美直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 按測試類型

  • 概述
  • 2022 年和 2030 年北美直接面對消費者的基因測試市場收入佔有率，按測試類型分類 (%)
  • 血統測試
  • 營養基因組學測試
  • 預測測試
  • 營運商測試
  • 其他

第 8 章：北美直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 按技術分類

  • 概述
  • 2022 年和 2030 年北美直接面對消費者的基因檢測市場收入佔有率（按技術分類）（%）
  • 全基因組定序
  • 單核苷酸多態性晶片
  • 針對性分析
  • 其他

第 9 章：北美直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 按配銷通路

  • 概述
  • 2022 年和 2030 年北美直接面對消費者的基因檢測市場收入佔有率（按配銷通路分類）（%）
  • 線上平台
  • 線下平台

第 10 章：北美直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 國家分析

  • 美國
  • 加拿大
  • 墨西哥

第 11 章：北美直接面對消費者的基因檢測市場-產業格局

  • 概述
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 12 章：公司簡介

  • Ancestry Genomics Inc
  • Color Health Inc
  • Helix Inc
  • Myriad Genetics, Inc.
  • Living DNA Ltd
  • 26andMe Inc
  • Genetic Technologies Ltd
  • Gene By Gene Ltd
  • Full Genomes Corp Inc

第 13 章：附錄

Product Code: BMIRE00029622

The North America Direct-to-Consumer genetic testing market was valued at US$ 716.40 million in 2022 and is expected to reach US$ 3,041.12 million by 2030; it is estimated to grow at a CAGR of 19.8% from 2022 to 2030.

Growing Incidence of Genetic Disorders Fuels the North America Direct-to-Consumer Genetic Testing Market

The global burden of genetic diseases is increasing. According to an article published in 2022 by The Guardian, ~5% of the world's population is affected by sickle cell disease, and approximately 300,000 babies are born with sickle cell anemia worldwide every year. The World Health Organization estimates that 10 in 1,000 people are affected. This means 70 to 80 million people worldwide live with one of these diseases. In 2020, the Online Mendelian Inheritance in Man (OMIM) resource listed 6,594 diseases with known molecular genetic defects, comprising 4,225 genes. This number is continuously increasing to approximately 50-60 new genetic diseases annually, as per the Orphanet and OMIM databases. The NIH Undiagnosed Diseases Program and Network and the International Rare Diseases Research Consortium are a few initiatives further accelerating the discovery rate of novel genetic diseases.

According to the CDC, 1 in 500 African Americans are diagnosed with sickle cell disease, and the autosomal recessive mutation is carried by 1 in 12 African Americans. According to the Alzheimer's Association, by 2023, nearly 6.7 million Americans aged 65 will have Alzheimer's-related dementia. Furthermore, the number is expected to rise to 13.8 million by 2060, with no breakthrough that either slows or cures the disease.

The incidence of genetic disorders in newborns is also increasing. According to the World Health Organization 2022 report, neural tube defects, Down syndrome, and heart defects are a few common severe congenital disabilities. According to the CDC, in the US, Down syndrome affects nearly 6,000 newborn babies yearly, one in 700 babies; and in India, every year, nearly 23,000 to 29,000 children, one in 831, have Down syndrome. According to the report titled "Neural tube defects: Different types and a brief overview of the neurulation process and its clinical implications," published in the Journal of Family Medicine and Primary Care in 2021, more than 300,000 cases of Neural tube defects (NTDs) are recorded worldwide each year. These factors are encouraging the introduction of genetic testing for inherited diseases.

Therefore, the increasing incidence of genetic disorders worldwide boosts the Direct-to-Consumer genetic testing market growth.

North America Direct-to-Consumer Genetic Testing Market Overview

The North America Direct-to-Consumer genetic testing market is segmented into the US, Canada, and Mexico. North America accounts for a significant market share owing to the growing prevalence of genetic diseases, high spending on research and development, product approvals by the US Food and Drug Administration (FDA), and technological advances. The presence of large healthcare businesses and the growing usage of Direct-to-Consumer genetic testing would continue to offer opportunities for market growth in the region during the period 2022-2030. Further, rising support from governments to address growing concerns about genetic diseases favors the Direct-to-Consumer genetic testing market progress in North America.

North America Direct-to-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)

North America Direct-to-Consumer Genetic Testing Market Segmentation

The North America Direct-to-Consumer genetic testing market is segmented into test type, technology, distribution channel, and country.

Based on test type, the North America Direct-to-Consumer genetic testing market is segmented into ancestry testing, predictive testing, nutrigenomics testing, carrier testing, and others. The ancestry testing market segment held the largest share in 2022.

In terms of technology, the North America Direct-to-Consumer genetic testing market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held the largest share in 2022.

Based on distribution channel, the North America Direct-to-Consumer genetic testing market is bifurcated into online and offline. The online segment held a larger share in 2022.

Based on country, the North America Direct-to-Consumer genetic testing market is segmented the US, Canada, and Mexico. The US dominated the North America Direct-to-Consumer genetic testing market in 2022.

Ancestry Genomics Inc, Color Health Inc, Helix Inc, Myriad Genetics, Inc., Living DNA Ltd, 23andMe Inc, Genetic Technologies Ltd, Gene by Gene Ltd, and Full Genomes Corp Inc are some of the leading companies operating in the North America Direct-to-Consumer genetic testing market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Direct-to-Consumer Genetic Testing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. North America Direct-to-Consumer Genetic Testing Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Incidence of Genetic Disorders
    • 5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
  • 5.4 Future Trends
    • 5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
  • 5.5 Impact Analysis

6. Direct-to-Consumer Genetic Testing Market - North America Market Analysis

  • 6.1 Overview
  • 6.2 North America Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 - 2030

7. North America Direct-to-Consumer genetic testing market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 North America Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 Ancestry Testing
    • 7.3.1 Overview
    • 7.3.2 Ancestry Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Nutrigenomics Testing
    • 7.4.1 Overview
    • 7.4.2 Nutrigenomics Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Predictive Testing
    • 7.5.1 Overview
    • 7.5.2 Predictive Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Carrier Testing
    • 7.6.1 Overview
    • 7.6.2 Carrier Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Direct-to-Consumer genetic testing market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 North America Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Whole Genome Sequencing
    • 8.3.1 Overview
    • 8.3.2 Whole Genome Sequencing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Single Nucleotide Polymorphism Chips
    • 8.4.1 Overview
    • 8.4.2 Single Nucleotide Polymorphism Chips: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Targeted Analysis
    • 8.5.1 Overview
    • 8.5.2 Targeted Analysis: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Direct-to-Consumer genetic testing market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 North America Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Online Platform
    • 9.3.1 Overview
    • 9.3.2 Online Platform: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Offline Platform
    • 9.4.1 Overview
    • 9.4.2 Offline Platform: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 North America Direct-to-Consumer Genetic Testing Market, by Key Country- Revenue (2022) (US$ Mn)
    • 10.1.1 North America Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
      • 10.1.1.1 US: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.2 US: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 US: North America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2 US: North America Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.3 US: North America Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.3 Canada: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.4 Canada: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Canada: North America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2 Canada: North America Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Canada: North America Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.5 Mexico: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.6 Mexico: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Mexico: North America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2 Mexico: North America Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.6.3 Mexico: North America Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)

11. North America Direct-to-Consumer Genetic Testing Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Ancestry Genomics Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Color Health Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Helix Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Myriad Genetics, Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Living DNA Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 26andMe Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Genetic Technologies Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Gene By Gene Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Full Genomes Corp Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Direct-to-Consumer genetic testing market Segmentation
  • Table 2. US: North America Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Canada: North America Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Canada: North America Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada: North America Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Mexico: North America Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Mexico: North America Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Mexico: North America Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Organic Developments Done by Companies
  • Table 12. Inorganic Developments Done by Companies
  • Table 13. Glossary of Terms, North America Direct-to-Consumer Genetic Testing Market

List Of Figures

  • Figure 1. North America Direct-to-Consumer genetic testing market Segmentation, By Country
  • Figure 2. PEST Analysis
  • Figure 3. North America Direct-to-Consumer Genetic Testing Market: Key Industry Dynamics
  • Figure 4. North America Direct-to-Consumer Genetic Testing Market: Impact Analysis of Drivers and Restraints
  • Figure 5. North America Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. North America Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 7. Ancestry Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Nutrigenomics Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Predictive Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Carrier Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 13. Whole Genome Sequencing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Single Nucleotide Polymorphism Chips: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Targeted Analysis: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Others: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. North America Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 18. Online Platform: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Offline Platform: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Direct-to-Consumer Genetic Testing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 21. North America Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
  • Figure 22. US: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Canada: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Mexico: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)